查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户
市场调查报告书
商品编码
1452576

欧洲分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户

Europe Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User
出版日期: | 出版商: The Insight Partners | 英文 134 Pages | 订单完成后即时交付

价格

欧洲分子诊断市场预计将从2022年的45.9254亿美元成长到2030年的112.2577亿美元。预计2022年至2030年CAGR为11.8%。

相关疾病发生率激增推动欧洲分子诊断市场

分子诊断程序可用于检测多种疾病，例如肿瘤疾病、传染病、心臟病和免疫系统疾病；它们也可以用于基因测试，使用 DNA 和 RNA 等遗传物质来诊断不同的疾病。癌症是全世界死亡的主要原因之一。及早发现这种疾病有助于防止患者死亡。根据 UK.GOV 2021 年 11 月 22 日发布的资料，COVID-19 的感染率为每 10 万人约 422.7 人。因此，目标疾病盛行率的上升推动了分子诊断市场的成长。

欧洲分子诊断市场概况

欧洲分子诊断市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区在全球分子诊断市场中占有重要份额，预计 2022 年至 2030 年CAGR将强劲。欧洲市场的成长归因于生命科学研究的不断增长以及政府对传染病检测投资的增加。

慢性阻塞性肺病 (COPD)、糖尿病、癌症和关节炎等慢性疾病如果不及时治疗可能会危及生命。例如，慢性淋巴球白血病（CLL）是德国最常见的白血病类型。根据德国《Arzteblatt》报道，德国 CLL 的盛行率约为每 10 万人中 6 例；每年有近 850 名女性和 1,000 名男性死于 CLL。

欧洲分子诊断市场收入及 2030 年预测（百万美元）

欧洲分子诊断市场细分

欧洲分子诊断市场分为疾病领域、技术、产品和服务、最终用户和国家。

根据疾病领域，欧洲分子诊断市场分为传染病、肿瘤、基因检测、心臟病、免疫系统疾病等。到 2022 年，传染病领域将占据欧洲最大的分子诊断市场。

根据技术，欧洲分子诊断市场分为聚合酶炼式反应（PCR）、原位杂交、等温核酸扩增技术（INAAT）、DNA定序和下一代定序（NGS）、DNA微阵列等。聚合酶链反应 (PCR) 领域在 2022 年占据欧洲最大的分子诊断市场份额。聚合酶链反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。

根据产品和服务，欧洲分子诊断市场分为检测和试剂盒、仪器、服务和软体。到 2022 年，检测和试剂盒领域将占据欧洲最大的分子诊断市场。

根据最终用户，欧洲分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。到 2022 年，诊断实验室领域将占据欧洲最大的分子诊断市场。

根据国家/地区，欧洲分子诊断市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022年，德国在欧洲分子诊断市场占据主导地位。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG 和 Novartis AG 是欧洲分子诊断领域的一些领先公司市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲分子诊断市场格局

  • 概述
  • PEST分析
    • 欧洲PEST分析

第 5 章：欧洲分子诊断市场 - 主要产业动态

  • 主要市场驱动因素：
    • 新产品的开发和即时检测需求的增加
    • 相关疾病的盛行率激增
  • 市场限制
    • 与分子测试相关的局限性
  • 市场机会
    • 分子诊断技术的进步
  • 未来的趋势
    • 个性化医疗中的分子诊断
  • 影响分析：

第 6 章：分子诊断市场 - 欧洲市场分析

  • 欧洲分子诊断市场收入，2022 - 2030

第 7 章：欧洲分子诊断市场 - 2030 年收入与预测 - 按疾病领域

  • 概述
  • 2022 年及 2030 年欧洲分子诊断市场收入份额，依疾病领域划分（%）
  • 肿瘤学
  • 传染病
  • 基因检测
  • 心臟病
  • 免疫系统疾病
  • 其他的

第 8 章：欧洲分子诊断市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年欧洲分子诊断市场收入份额（按技术划分）（%）
  • 聚合酶炼式反应
  • 等温核酸扩增技术（INAAT）
  • DNA 定序和二代定序 (NGS)
  • DNA微阵列
  • 原位杂交 (ISH)
  • 其他的

第 9 章：欧洲分子诊断市场 - 收入和 2030 年预测 - 按产品和服务

  • 概述
  • 2022 年和 2030 年欧洲分子诊断市场收入份额（按产品和服务划分）（%）
  • 检测方法和试剂盒
  • 仪器
  • 服务和软体

第 10 章：欧洲分子诊断市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年欧洲分子诊断市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
  • 其他的

第 11 章：欧洲分子诊断市场 - 国家分析

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第12章：欧洲分子诊断市场产业格局

  • 概述
  • 市场上公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 13 章：欧洲分子诊断市场，主要公司概况

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG

第 14 章：附录

Product Code: TIPRE00026715

The Europe molecular diagnostics market is expected to grow from US$ 4,592.54 million in 2022 to US$ 11,225.77 million by 2030. It is estimated to grow at a CAGR of 11.8% from 2022 to 2030.

Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market

Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.

Europe Molecular Diagnostics Market Overview

The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022-2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.

Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Arzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.

Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Molecular Diagnostics Market Segmentation

The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.

Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.

Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.

Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis

5. Europe Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - Europe Market Analysis

  • 6.1 Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 qPCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Molecular Diagnostics Market - Country Analysis

  • 11.1 Europe Molecular Diagnostics Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
      • 11.1.1.1 Europe Molecular Diagnostics Market by Country
    • 11.1.2 Germany
      • 11.1.2.1 Overview
    • 11.1.3 Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.4 Germany: Molecular Diagnostics Market, by Disease Area
    • 11.1.5 Germany: Molecular Diagnostics Market, by Technology
      • 11.1.5.1 Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.6 Germany: Molecular Diagnostics Market, by Product and Services
    • 11.1.7 Germany: Molecular Diagnostics Market, by End User
    • 11.1.8 UK
      • 11.1.8.1 Overview
    • 11.1.9 UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.10 UK: Molecular Diagnostics Market, by Disease Area
    • 11.1.11 UK: Molecular Diagnostics Market, by Technology
      • 11.1.11.1 UK: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.12 UK: Molecular Diagnostics Market, by Product and Services
    • 11.1.13 UK: Molecular Diagnostics Market, by End User
    • 11.1.14 France
      • 11.1.14.1 Overview
    • 11.1.15 France: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.16 France: Molecular Diagnostics Market, by Disease Area
    • 11.1.17 France: Molecular Diagnostics Market, by Technology
      • 11.1.17.1 France: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.18 France: Molecular Diagnostics Market, by Product and Services
    • 11.1.19 France: Molecular Diagnostics Market, by End User
    • 11.1.20 Italy
      • 11.1.20.1 Overview
    • 11.1.21 Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.22 Italy: Molecular Diagnostics Market, by Disease Area
    • 11.1.23 Italy: Molecular Diagnostics Market, by Technology
      • 11.1.23.1 Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.24 Italy: Molecular Diagnostics Market, by Product and Services
    • 11.1.25 Italy: Molecular Diagnostics Market, by End User
    • 11.1.26 Spain
      • 11.1.26.1 Overview
    • 11.1.27 Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.28 Spain: Molecular Diagnostics Market, by Disease Area
    • 11.1.29 Spain: Molecular Diagnostics Market, by Technology
      • 11.1.29.1 Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
        • 11.1.29.1.1 Spain: Molecular Diagnostics Market, by Product and Services
    • 11.1.30 Spain: Molecular Diagnostics Market, by End User
    • 11.1.31 Rest of Europe
      • 11.1.31.1 Overview
    • 11.1.32 Rest of Europe: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.33 Rest of Europe: Molecular Diagnostics Market, by Disease Area
    • 11.1.34 Rest of Europe: Molecular Diagnostics Market, by Technology
      • 11.1.34.1 Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.35 Rest of Europe: Molecular Diagnostics Market, by Product and Services
    • 11.1.36 Rest of Europe: Molecular Diagnostics Market, by End User

12. Europe Molecular Diagnostics Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Europe Molecular Diagnostics Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Agilent Technologies Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Qiagen NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Illumina Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Danaher
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Siemens Healthineers AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Novartis AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Molecular Diagnostics Market Segmentation
  • Table 2. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Disease Area
  • Table 3. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 4. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 7. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 9. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 12. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 14. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 18. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 19. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 20. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 21. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 23. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 24. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 25. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 26. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 27. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 28. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 29. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 30. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 31. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 32. Organic Developments Done By Companies
  • Table 33. Inorganic Developments Done By Companies
  • Table 34. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. Europe - PEST Analysis
  • Figure 2. Europe Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 6. Oncology: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Infectious Disease: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Genetic Testing: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Cardiac Diseases: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immune System Disorders: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. RT-PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. qPCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Multiplex PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. DNA microarrays: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 24. Assays and Kits: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Instruments: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Services and Software: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals and Clinics: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Research and Academic Institutes: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe Molecular Diagnostics Market, By country, 2022 ($Mn)
  • Figure 33. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 34. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Growth Strategies Done by the Companies in the Market (%)